Kolltan Pharmaceuticals

Kolltan Pharmaceuticals

Developing novel biologic drugs targeting receptor tyrosine kinases (RTKs) for oncology and immunology.

HQ location
New Haven, United States
Website
kolltan.com
Launch date
Employees
2-10 people
Enterprise value
$235m
https://twitter.com/arthurajrhttp://www.facebook.com/pages/Kolltan-Pharmaceuticals-Inc/193169757364347https://www.linkedin.com/company/kolltan-pharmaceuticals-inc./
Authorizing premium user...